000 | 00992 a2200277 4500 | ||
---|---|---|---|
005 | 20250514065654.0 | ||
264 | 0 | _c20030623 | |
008 | 200306s 0 0 eng d | ||
022 | _a0172-780X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPawlikowski, Marek | |
245 | 0 | 0 |
_aPerspectives of new potential therapeutic applications of somatostatin analogs. _h[electronic resource] |
260 |
_bNeuro endocrinology letters _c |
||
300 |
_a21-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAcromegaly _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
650 | 0 | 4 |
_aEndocrine Gland Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aHormone Antagonists _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReceptors, Somatostatin _xdrug effects |
650 | 0 | 4 |
_aSomatostatin _xanalogs & derivatives |
700 | 1 | _aMelen-Mucha, Gabriela | |
773 | 0 |
_tNeuro endocrinology letters _gvol. 24 _gno. 1-2 _gp. 21-7 |
|
999 |
_c12532161 _d12532161 |